B Cell Strategy to Maintain Remission in ANCA-associated Vasculitides?

被引：3
|
作者：
Adler, Sabine
Villiger, Peter M. [1 ]
机构：
[1] Univ Hosp Bern, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland
来源：
JOURNAL OF RHEUMATOLOGY | 2012年 / 39卷 / 01期
关键词：
WEGENERS-GRANULOMATOSIS; MAINTENANCE THERAPY; RITUXIMAB; CYCLOPHOSPHAMIDE; DEPLETION;
D O I：
10.3899/jrheum.111313
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [31] ANCA-associated vasculitides: what nephrologists need to know
    Jourde-Chiche, Noemie
    Augusto, Jean-Francois
    Faguer, Stanislas
    NEPHROLOGIE & THERAPEUTIQUE, 2024, 20 (07): : 666 - 673
  • [32] Remission induction in ANCA-associated vasculitis
    Hellmich, B.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (02): : 194 - 195
  • [33] De-escalation of therapy in ANCA-associated vasculitides
    Schinke, S.
    Riemekasten, G.
    Lamprecht, P.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (01): : 15 - 20
  • [34] Immune regulatory mechanisms in ANCA-associated vasculitides
    Lepse, Nikola
    Abdulahad, Wayel H.
    Kallenberg, Cees G. M.
    Heeringa, Peter
    AUTOIMMUNITY REVIEWS, 2011, 11 (02) : 77 - 83
  • [35] New advances in the pathogenesis of ANCA-associated vasculitides
    Chen, M.
    Kallenberg, C. G. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (01) : S108 - S114
  • [36] Pathogenesis of ANCA-associated vasculitides in 2021: An update
    Neel, A.
    Degauque, N.
    Bruneau, S.
    Braudeau, C.
    Bucchia, M.
    Caristan, A.
    De Mornac, D.
    Genin, V
    Glemain, A.
    Oriot, C.
    Rimbert, M.
    Brouard, S.
    Josien, R.
    Hamidou, M.
    REVUE DE MEDECINE INTERNE, 2022, 43 (02): : 89 - 97
  • [37] Genetics of ANCA-associated vasculitides: HLA and beyond
    Alberici, F.
    Martorana, D.
    Bonatti, F.
    Gioffredi, A.
    Lyons, P. A.
    Vaglio, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S90 - S97
  • [38] Towards diagnostic criteria for the ANCA-associated vasculitides
    Luqmani, R. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) : S57 - S57
  • [39] Treatment of refractory and/or severe ANCA-associated systemic necrotizing vasculitides
    Guillevin, Loic
    Pagnoux, Christian
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (01): : 89 - 91
  • [40] Current Guidelines on ANCA-associated Vasculitides Common Features and Differences
    Hellmich, B.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (02): : 133 - 142
12345